SCHEMBL6537308

SCHEMBL6537308

CCc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1CCn1cnc2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.41
LCK P06239 1/20 0.39
HSD17B13 Q7Z5P4 2/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
NPC1 O15118 2/20 0.38
EGLN3 Q9H6Z9 1/20 0.38
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
HTT P42858 3/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
IDO1 P14902 1/20 0.36
SLC16A3 O15427 1/20 0.36
PTGES O14684 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538294 0.91 MEN1 (0.42) POLBLCKHSD17B13KMT2AMEN1
SCHEMBL6538125 0.81 SLC16A3 (0.41) POLBKMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL6538234 0.81 CYP1A2 (0.41) KMT2AMEN1LMNASMN1; SMN2HTT
SCHEMBL6537689 0.80 SLC16A3 (0.40) POLBKMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL6537946 0.80 MEN1 (0.41) POLBKMT2AMEN1LMNAGAA
SCHEMBL6537729 0.80 SLC16A3 (0.40) POLBKMT2AMEN1SMN1; SMN2HTT
SCHEMBL6538162 0.80 SLC16A3 (0.42) KMT2AMEN1SMN1; SMN2HTTCRHBP
SCHEMBL6537711 0.79 TYK2 (0.42) POLBKMT2AMEN1GAARAB9A
SCHEMBL6537622 0.79 TYK2 (0.42) POLBKMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL6538375 0.79 SLC16A3 (0.39) POLBKMT2AMEN1SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed